“… 4 , 19 , 44 , 67 , 105 , 108 , 110 , 113-116 , 119 Four studies reported dropouts and reported the number of participants who completed the follow up. 101 , 105 , 107 , 118 Based on the EPHPP guidelines, 20 studies had an overall final rating of weak, 6 studies were rated as moderate, and only 1 study was rated as strong (4%). 106 Data pooling and meta-analysis was not possible due to heterogeneity across studies in terms of clinical features, eg, population characteristics, indications, supplementation strategies, and additional interventions (facelift, additional injections), and methodologic characteristics, eg, assessment tools, study design, and follow up.…”